| # | Title | Journal | Year | Citations |
|---|
| 1 | Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement | PLoS Medicine | 2009 | 50,671 |
| 2 | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | BMJ: British Medical Journal | 2009 | 36,486 |
| 3 | The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | BMJ: British Medical Journal | 2011 | 23,287 |
| 4 | Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement | Annals of Internal Medicine | 2009 | 20,458 |
| 5 | PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation | Annals of Internal Medicine | 2018 | 15,209 |
| 6 | The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration | PLoS Medicine | 2009 | 13,772 |
| 7 | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration | BMJ: British Medical Journal | 2009 | 13,452 |
| 8 | Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement | Journal of Clinical Epidemiology | 2009 | 9,774 |
| 9 | Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement | International Journal of Surgery | 2010 | 8,663 |
| 10 | ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions | BMJ, The | 2016 | 8,654 |
| 11 | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Journal of Clinical Epidemiology | 2009 | 8,425 |
| 12 | CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials | BMJ: British Medical Journal | 2010 | 5,910 |
| 13 | Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide | BMJ, The | 2014 | 5,661 |
| 14 | CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials | BMJ: British Medical Journal | 2010 | 5,319 |
| 15 | CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials | BMC Medicine | 2010 | 4,939 |
| 16 | Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials | BMJ: British Medical Journal | 2011 | 4,743 |
| 17 | AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both | BMJ: British Medical Journal | 2017 | 4,681 |
| 18 | From best evidence to best practice: effective implementation of change in patients' care | Lancet, The | 2003 | 3,640 |
| 19 | The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | International Journal of Surgery | 2021 | 3,487 |
| 20 | SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials | BMJ, The | 2013 | 3,435 |
| 21 | Guidelines for the use and interpretation of assays for monitoring autophagy | Autophagy | 2012 | 3,122 |
| 22 | Lost in knowledge translation: Time for a map? | Journal of Continuing Education in the Health Professions | 2006 | 3,097 |
| 23 | Decision aids for people facing health treatment or screening decisions | The Cochrane Library | 2017 | 2,780 |
| 24 | CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials | Annals of Internal Medicine | 2010 | 2,752 |
| 25 | COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up | Journal of the American College of Cardiology | 2020 | 2,392 |
| 26 | Cellular and Molecular Regulation of Muscle Regeneration | Physiological Reviews | 2004 | 2,200 |
| 27 | PRDM16 controls a brown fat/skeletal muscle switch | Nature | 2008 | 1,997 |
| 28 | STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies | BMJ, The | 2015 | 1,914 |
| 29 | What is an adequate sample size? Operationalising data saturation for theory-based interview studies | Psychology and Health | 2010 | 1,833 |
| 30 | Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies | JAMA - Journal of the American Medical Association | 2018 | 1,783 |
| 31 | Cetuximab for the Treatment of Colorectal Cancer | New England Journal of Medicine | 2007 | 1,778 |
| 32 | A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems | Implementation Science | 2017 | 1,734 |
| 33 | Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 | JAMA Oncology | 2019 | 1,691 |
| 34 | Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force | Value in Health | 2013 | 1,657 |
| 35 | Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma | JAMA - Journal of the American Medical Association | 2017 | 1,619 |
| 36 | Satellite Cells and the Muscle Stem Cell Niche | Physiological Reviews | 2013 | 1,604 |
| 37 | Knowledge translation of research findings | Implementation Science | 2012 | 1,586 |
| 38 | A Modification of the Elixhauser Comorbidity Measures Into a Point System for Hospital Death Using Administrative Data | Medical Care | 2009 | 1,573 |
| 39 | CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials | International Journal of Surgery | 2012 | 1,546 |
| 40 | CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials | Journal of Clinical Epidemiology | 2010 | 1,500 |
| 41 | Effects of Exercise on Glycemic Control and Body Mass in Type 2 Diabetes Mellitus | JAMA - Journal of the American Medical Association | 2001 | 1,478 |
| 42 | Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 | Autophagy | 2021 | 1,430 |
| 43 | AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews | Journal of Clinical Epidemiology | 2009 | 1,427 |
| 44 | A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth | Cancer Cell | 2007 | 1,374 |
| 45 | Developing a quality criteria framework for patient decision aids: online international Delphi consensus process | BMJ: British Medical Journal | 2006 | 1,373 |
| 46 | Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis | Nature Cell Biology | 2010 | 1,299 |
| 47 | Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial | Lancet, The | 2017 | 1,261 |
| 48 | Increasing value and reducing waste in research design, conduct, and analysis | Lancet, The | 2014 | 1,186 |
| 49 | Oncolytic virotherapy | Nature Biotechnology | 2012 | 1,150 |
| 50 | Asymmetric Self-Renewal and Commitment of Satellite Stem Cells in Muscle | Cell | 2007 | 1,145 |
